Pseudomonas Infections

"Pseudomonas Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Infections with bacteria of the genus PSEUDOMONAS.

Descriptor ID	D011552
MeSH Number(s)	C01.252.400.739
Concept/Terms	Pseudomonas Infections Pseudomonas Infections Infections, Pseudomonas Infection, Pseudomonas Pseudomonas Infection Pseudomonas aeruginosa Infection Pseudomonas aeruginosa Infection Pseudomonas aeruginosa Infections

Below are MeSH descriptors whose meaning is more general than "Pseudomonas Infections".

Diseases [C]
Bacterial Infections and Mycoses [C01]
Bacterial Infections [C01.252]
Gram-Negative Bacterial Infections [C01.252.400]
Pseudomonas Infections [C01.252.400.739]

Below are MeSH descriptors whose meaning is related to "Pseudomonas Infections".

Below are MeSH descriptors whose meaning is more specific than "Pseudomonas Infections".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Pseudomonas Infections" by people in this website by year, and whether "Pseudomonas Infections" was a major or minor topic of these publications.

Bar chart showing 55 publications over 23 distinct years, with a maximum of 6 publications in 2011 and 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1992	1	0	1
1994	2	1	3
1995	1	0	1
1996	1	0	1
1997	0	1	1
2002	1	3	4
2004	0	1	1
2005	2	0	2
2006	1	0	1
2007	0	1	1
2008	1	0	1
2009	1	0	1
2010	2	3	5
2011	4	2	6
2012	1	1	2
2013	0	2	2
2014	1	1	2
2015	4	0	4
2016	4	0	4
2017	2	0	2
2018	1	0	1
2019	6	0	6
2020	2	1	3

Below are the most recent publications written about "Pseudomonas Infections" by people in Profiles.

Al Ahmar R, Kirby BD, Yu HD. Culture of Small Colony Variant of Pseudomonas aeruginosa and Quantitation of its Alginate. J Vis Exp. 2020 02 22; (156).

View in: PubMed
Valentine ME, Kirby BD, Yu HD. Generation of In-Frame Gene Deletion Mutants in Pseudomonas aeruginosa and Testing for Virulence Attenuation in a Simple Mouse Model of Infection. J Vis Exp. 2020 01 08; (155).

View in: PubMed
Ponce MC, Svendsen E, Steed L, Flume PA. Impact of a Reduction in Susceptibility Testing for Pseudomonas aeruginosa in a Cystic Fibrosis Program. Am J Respir Crit Care Med. 2020 01 01; 201(1):114-116.

View in: PubMed
Waters VJ, Kidd TJ, Canton R, Ekkelenkamp MB, Johansen HK, LiPuma JJ, Bell SC, Elborn JS, Flume PA, VanDevanter DR, Gilligan P. Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung Infections. Clin Infect Dis. 2019 10 30; 69(10):1812-1816.

View in: PubMed
Kirby BD, Al Ahmar R, Withers TR, Valentine ME, Valentovic M, Long TE, Gaskins JR, Yu HD. Efficacy of Aerosolized Rifaximin versus Tobramycin for Treatment of Pseudomonas aeruginosa Pneumonia in Mice. Antimicrob Agents Chemother. 2019 07; 63(7).

View in: PubMed
Panmanee W, Su S, Schurr MJ, Lau GW, Zhu X, Ren Z, McDaniel CT, Lu LJ, Ohman DE, Muruve DA, Panos RJ, Yu HD, Thompson TB, Tseng BS, Hassett DJ. The anti-sigma factor MucA of Pseudomonas aeruginosa: Dramatic differences of a mucA22 vs. a ?mucA mutant in anaerobic acidified nitrite sensitivity of planktonic and biofilm bacteria in vitro and during chronic murine lung infection. PLoS One. 2019; 14(6):e0216401.

View in: PubMed
Nichols DP, Durmowicz AG, Field A, Flume PA, VanDevanter DR, Mayer-Hamblett N. Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities. Ann Am Thorac Soc. 2019 05; 16(5):534-539.

View in: PubMed
Valentine ME, Kirby BD, Withers TR, Johnson SL, Long TE, Hao Y, Lam JS, Niles RM, Yu HD. Generation of a highly attenuated strain of Pseudomonas aeruginosa for commercial production of alginate. Microb Biotechnol. 2020 01; 13(1):162-175.

View in: PubMed
Elizabeth Davis S, Ham J, Hucks J, Gould A, Foster R, Ann Justo J, Nicolau DP, Bookstaver PB. Use of continuous infusion ceftolozane-tazobactam with therapeutic drug monitoring in a patient with cystic fibrosis. Am J Health Syst Pharm. 2019 Apr 08; 76(8):501-504.

View in: PubMed
Al-Jaghbeer MJ, Justo JA, Owens W, Kohn J, Bookstaver PB, Hucks J, Al-Hasan MN. Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study. Infection. 2018 Aug; 46(4):487-494.

View in: PubMed

People

Explore

Similar Concepts

Top Journals